Appointments, Acquisition Agreements, Collaborations, and Earnings Release Schedule - Research Reports on Pepsico, Delphi, Express Scripts, Omnicom and TJX

NEW YORK, October 13, 2014 /PRNewswire/ --

Today, Analysts Review released its research reports regarding Pepsico, Inc. (NYSE: PEP), Delphi Automotive PLC (NYSE: DLPH), Express Scripts Holding Company (NASDAQ: ESRX), Omnicom Group Inc. (NYSE: OMC) and The TJX Companies, Inc. (NYSE: TJX). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7118-100free.

--
Pepsico, Inc. Research Reports
On October 7, 2014, Pepsico, Inc. (Pepsico) announced that the Company has appointed Tony West as Executive Vice President of Government Affairs, General Counsel and Corporate Secretary, effective November 24, 2014. The Company stated that in his new role, Mr. West, who succeeds Larry Thompson, will be responsible for PepsiCo's worldwide legal function and government affairs organization, as well as its global compliance function and the PepsiCo Foundation. He will report to PepsiCo Chairman and CEO Indra Nooyi. Pepsico informed that prior to his new role, Tony was associated with United States Department of Justice where he served as Associate Attorney General of the United States. "Tony is a tremendous addition to the PepsiCo management team," said Nooyi. "He is a world-class leader who brings a strong set of skills, experiences and values to PepsiCo. We will benefit greatly from Tony's leadership and expertise." The full research reports on Pepsico are available to download free of charge at:

http://www.analystsreview.com/Oct-13-2014/PEP/report.pdf

--
Delphi Automotive PLC Research Reports
On September 30, 2014, Delphi Automotive PLC (Delphi) announced that the Company has entered into a definitive agreement to acquire media connectivity module supplier, Unwired Technology LLC (Unwired), thus expanding its data and media connectivity capabilities. Delphi informed that the acquisition of Unwired follows its recently announced agreement to acquire Antaya Technologies Corp., a leading supplier of proprietary on-glass connectors. The Company added that the two acquisitions significantly enhance Delphi's product offerings in the rapidly growing automotive electrical connectors business, giving it more ways to meet its customers' needs. As per Delphi, the transaction is expected to close in Q4 2014. "Media connectivity is a high-growth segment as auto manufacturers respond quickly to consumers' increasing desire to integrate their smartphones and tablets in their vehicles," said Rodney O'Neal, Delphi CEO and President. "Unwired's products strengthen our overall electrical architecture and electrical connector offerings, which is supporting increased electronics content per vehicle." The full research reports on Delphi are available to download free of charge at:

http://www.analystsreview.com/Oct-13-2014/DLPH/report.pdf

--
Express Scripts Holding Company Research Reports
On October 1, 2014, Express Scripts Holding Company (Express Scripts) announced that the Company has collaborated with Walgreens to create Value-Driven Medicare Prescription Drug Plan Pharmacy Network. As per Express Scripts, the Company's two nationally available 2015 Express Scripts Medicare® Prescription Drug Plans (PDP) will offer a preferred retail pharmacy network featuring Walgreens, thus helping America's seniors obtain more value, choice and clinical support for their Medicare dollars. The Company added that Medicare beneficiaries who enroll in the Express Scripts Medicare Value or Choice plans for 2015 can save significantly - with $0 or $1 copayments, respectively, for Tier 1 generic medications - when using one of the more than 27,000 pharmacies in the plans' preferred retail network which includes approximately 8,200 Walgreens pharmacies nationwide and more than 18,500 community pharmacies. As per Express Scripts, enrollment for the 2015 plan year begins October 15, 2014, and ends December 7, 2014. The full research reports on Express Scripts are available to download free of charge at:

http://www.analystsreview.com/Oct-13-2014/ESRX/report.pdf

--
Omnicom Group Inc. Research Reports
On September 29, 2014, Omnicom Group Inc. (Omnicom) announced that it is the first holding company to partner with Atlas on the launch of their new ad serving platform. As per Omnicom, this strategic partnership will provide first-mover advantages to its clients who want the benefits of people-based marketing such as reaching people across devices and bridging the gap between impressions and offline purchases. Jonathan Nelson, CEO, Omnicom Digital - a business unit of Omnicom said, "We know that 65% of all shoppers use their mobile devices while out shopping, but, unfortunately, cookies don't work -- or don't work well -- on mobile devices and thus fall short when accompanying a customer on a shopping journey. Atlas is exciting because it solves that problem and works across multiple devices, thus building a bridge from a stationary, offline device such as a home PC to the mobile device that's right in the shopper's hand." The full research reports on Omnicom are available to download free of charge at:

http://www.analystsreview.com/Oct-13-2014/OMC/report.pdf

--
The TJX Companies, Inc. Research Reports
As per the Reporting Calendar section of The TJX Companies, Inc. (TJX) official website, the Company intends to release its Q3 FY 2015 earnings on November 18, 2014. According to the same section, the Company expects to hold a conference call on the same day to discuss results, operations and business trends. The full research reports on TJX are available to download free of charge at:

http://www.analystsreview.com/Oct-13-2014/TJX/report.pdf

--
About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.


===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] www.analystsreview.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] www.analystsreview.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] www.analystsreview.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Analysts Review